Abstract
Acute sinusitis is a very common infection in childhood, but its management remains a controversial issue. Antibacterials may be effective in selected children, but direct evidence is limited. One randomized, placebo-controlled trial has shown that amoxicillin or amoxicillin/clavulanate are better than placebo for children with symptoms of nasal discharge and cough that are persistent (over 10 days) and not improving. However, another placebo-controlled trial of the same agents did not demonstrate any benefit from antibacterials in a patient population selected with a clinical diagnosis of sinusitis of moderate severity, based on a composite clinical symptom score.
A systematic assessment of cure rates with various antibacterials shows no consistent differences between classes. Evidence on the use of ancillary measures and nasal corticosteroids is also limited. The only randomized, placebo-controlled trial of antihistamines and decongestants has shown no incremental benefit when given in addition to amoxicillin. Another placebo-controlled randomized trial showed some transient symptomatic improvement with the use of nasal corticosteroids. No randomized trials exist on the use of antral lavage in children with acute sinusitis. The current rates of antimicrobial resistance among commonly implicated pathogens should be considered in therapeutic decisions. However, there is no evidence from well-designed trials on specifically how to manage children at high risk of carrying resistant organisms. The inaccuracy of clinical signs and symptoms in documenting the diagnosis further complicates therapeutic decisions. Nevertheless, radiographic assessment does not meaningfully improve the accuracy of the diagnosis for uncomplicated cases, and it is not cost effective. In the absence of definitive evidence, treatment with amoxicillin 45 mg/kg/day in two divided doses may be used in selected patients with symptoms that are persistent and not improving. High doses (90 mg/kg in two divided doses) may also be considered, and amoxicillin/clavulanate may be a more appropriate choice when there is high risk of resistant pathogens, e.g. in a child attending a childcare center, or recent use of antibacterials. However, a considerable proportion of children, especially those with mild or improving symptoms, may not have to be treated at all.
Similar content being viewed by others
References
Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209–23
Wald ER. Sinusitis in children. N Engl J Med 1992; 326: 319–23
Ioannidis JPA, Lau J. Technical report: evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic overview. American Academy of Pediatrics. Pediatrics 2002; 108: E57
Ficnar B, Huzjak N, Oreskovic K, et al. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group. J Chemother 1997; 9: 38–43
Careddu P, Bellosta C, Tonelli P, et al. Efficacy and tolerability of brodimoprim in pediatric infections. J Chemother 1993; 5: 543–5
Wald ER, Reilly JS, Casselbrant M, et al. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr 1984; 104: 297–302
Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77: 795–800
Jeppesen F, Illum P. Pivampicillin (pondocillin) in the treatment of maxillary sinusitis. Acta Otolaryngol 1972; 74: 375–82
Simon MW. A prospective randomized study comparing the efficacy of amoxicillin-clavulanate, erythromycin-sulfisoxazole, cefaclor, and cefprozil in treating acute sinusitis of childhood. Adv Ther 1997; 14: 64–72
Hager C, Bamberg P, Dorn G, et al. The use of co-trimazine once daily in acute otitis media and maxillary sinusitis in children. J Int Med Res 1980; 8: 413–6
Helin I, Andreasson L, Jannert M, et al. Acute sinusitis in children: results of different therapeutic regimens. Helv Paediatr Acta 1982; 37: 83–8
Nylen O, Jeppsson PH, Branefors-Helander P. Acute sinusitis: a clinical bacteriological and serological study with special reference to Haemophilus influenzae. Scand J Infect Dis 1972; 4: 43–8
Gurses N, Kalayci AG, Islek I, et al. Cefuroxime axetil in the treatment of acute sinusitis in childhood. J Antimicrob Chemother 1996; 38: 547–50
Herz G, Gfeller J. Sinusitis in paediatrics. Chemotherapy 1977; 23: 50–7
Puhakka H, Virolainen E. Cefadroxil in the treatment of susceptible infections in infants and children. Drugs 1986; 32: 21–8
McLean DC. Sinusitis in children: lessons from twenty-five patients. Clin Pediatr (Phila) 1970; 9: 342–5
Aitken M, Taylor JA. Prevalence of clinical sinusitis in young children followed up by primary care pediatricians. Arch Pediatr Adolesc Med 1998; 152: 244–8
Ueda D, Yoto Y. The ten-day mark as a practical diagnostic approach for acute paranasal sinusitis in children. Pediatr Infect Dis J 1996; 15: 576–9
Revonta M, Suonpaa J. Diagnosis and follow-up of ultrasonographical sinus changes in children. Int J Pediatr Otorhinolaryngol 1982; 4: 301–8
McCormick DP, John SD, Swischuk LE, et al. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996; 35: 457–60
Barlan IB, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Allergy Asthma Immunol 1997; 78: 598–601
Garbutt JM, Goldstein M, Gellman E, et al. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001; 107: 619–25
Simon MW. Treatment of acute sinusitis in childhood with ceftibuten. Clin Pediatr 1999; 38: 269–72
Yilmaz G, Varan B, Yilmaz T, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Eur Arch Otorhinolaryngol 2000; 257: 256–9
Simon MW. Cefprozil vs amoxicillin in the treatment of childhood acute sinusitis. Int Pediatr 2000; 15: 93–6
Karadag A. Nasal saline for acute sinusitis [letter]. Pediatrics 2002; 109: 165
Mulrow CD, Linn WD, Gaul MK, et al. Assessing quality of a diagnostic test evaluation. J Gen Intern Med 1989; 4: 288–95
Garbutt JM, Gellman EF, Littenberg B. The development and validation of an instrument to assess acute sinus disease in children. Qual Life Res 1999; 8: 225–33
Sacco O, Tarantino V, Lantero S, et al. Nasal brushing: a clinically useful procedure in pediatric patients with rhinosinusitis. Int J Pediatr Otorhinolaryngol 1999; 50: 23–30
Kogutt MS, Swischuk LE. Diagnosis of sinusitis in infants and children. Pediatrics 1973; 52: 121–4
Watt-Boolsen S, Karle A. The clinical use of radiological examination of the maxillary sinuses. Clin Otolaryngol 1977; 2: 41–3
Van Buchem FL, Peeters MF, Knottnerus JA. Maxillary sinusitis in children. Clin Otolaryngol 1992; 17: 49–53
Jannert M, Andreasson L, Helin I, et al. Acute sinusitis in children: symptoms, clinical findings and bacteriology related to initial radiologic appearance. Int J Pediatr Otorhinolaryngol 1982; 4: 139–48
Glasier CM, Mallory Jr GB, Steele RW. Significance of opacification of the maxillary and ethmoid sinuses in infants. J Pediatr 1989; 114: 45–50
Wald ER, Milmoe GJ, Bowen A, et al. Acute maxillary sinusitis in children. N Engl J Med 1981; 304: 749–54
McAlister WH, Parker BR, Kushner DC, et al. Sinusitis in the pediatric population. American College of Radiology ACR appropriateness criteria [online]. Available from URL: http://www.acr.org/departments/appropriateness_criteria/toc.html [Accessed 2002 Nov 25]
Balk EM, Zucker DR, Engels EA, et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med 2001; 16: 701–11
American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics 2001; 108: 798–808
Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995, and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41: 292–7
Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1–9
Harris SJ, Wald ER, Senior BA, et al. The sinusitis debate. Pediatrics 2002; 109: 166–7
de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis: a meta-analysis. BMJ 1998; 317: 632–7
Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437–43
Ioannidis JP, Contopoulos-Ioannidis DG. Reporting of safety data from randomised trials. Lancet 1998; 352: 1752–3
Ioannidis JP, Chew P, Lau J. Standarized retrieval of side effects data for metaanalysis of safety outcomes: a feasibility study in acute sinusitis. J Clin Epidemiol 2002; 55: 619–26
Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother 2001; 48: 677–89
Takata GS, Chan LS, Shekelle P, et al. Evidence assessment of management of acute otitis media (I): the role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001; 108: 239–47
Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001; 286: 49–56
Physician’s desk reference (PDR). 57th ed. Medical Economics Company Inc. [online]. Available from URL: http://www.pdrnet.com [Accessed 2002 Nov 25]
Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–37
Bottenfield GW, Burch DJ, Hedrick JA, et al. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12h) of amoxicillin/clavulanate (augmentin) in the empiric treatment of pediatric acute otitis media caused by drugresistant Streptococcus pneumoniae. Pediatr Infect Dis J 1998; 17: 963–8
Acknowledgements
No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Contopoulos-Ioannidis, D.G., Ioannidis, J.P.A. & Lau, J. Acute Sinusitis in Children. Pediatr-Drugs 5, 71–80 (2003). https://doi.org/10.2165/00128072-200305020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-200305020-00001